Skip to main content
Top
Published in: Abdominal Radiology 5/2012

01-10-2012

RETRACTED ARTICLE: Diagnosis of rejection after liver transplantation: use of phosphorus-31 magnetic resonance spectroscopy (31P-MRS)

Authors: Tao Jiang, Shiyuan Liu, XiangSheng Xiao, XiaoFeng Tao, GuangHua Liu, JinLin Wang

Published in: Abdominal Radiology | Issue 5/2012

Login to get access

Abstract

Background

In vivo hepatic phosphorus-31 magnetic resonance spectroscopy (31P-MRS) provides non-invasive information about phospholipid metabolism. Aims: To delineate 31P-MRS abnormalities in patients with chronic rejection and to charactererize spectral changes by pathology.

Patients and methods

Sixty-six liver transplant recipients (18 with chronic rejection and 48 with normal graft function) and 38 controls (23 healthy volunteers and fifteen patients with biliary duct stricture) were studied with in vivo 31P-MRS. All the data and peak values were calibrated and calculated by the software of spectroscopy analysis GE, and the pH values were calculated by the Malloy’s formula, then the peak area ratios and altitudes of metabolites relative to adenosine triphosphate (β-ATP)and phosphate (Pi) were measured.

Results

(a) The peak area ratios and altitudes of PME and PDE in biliary duct stricture group and chronic rejection group were higher than those of healthy volunteer group and normal graft function group. Patients with chronic rejection had significant differences in the peak area ratios of PME: β-ATP (P < 0.05) and PDE: β-ATP (P < 0.05) and in the altitudes of PME: β-ATP (P < 0.05) as compared with the other groups. (b) The ratios of β-ATP/Pi decreased in biliary duct stricture group, while they increased in chronic rejection group. There was no difference between the four groups. There were similar changes in the ratios of PME/Pi, but there was significant difference between the chronic rejection group and the other three groups. (c) pH values increased in biliary duct stricture group and chronic rejection group, though the difference was not significant with the healthy control group. (d) Histological specimens showed focal loss of hepatocytes, degeneration, and hepatocytic atrophy.

Conclusions

31P-MRS imaging is valuable in detecting the metabolism of the liver after transplantation, and suggests that further investigation of alterations in the phospholipid metabolism may be a useful future direction of research.
Literature
1.
go back to reference Noack KB, Wiesner RH, Batts K et al. (1991) Severe ductopenic rejection with features of vanishing bile duct syndrome:clinical,biochemical and histological evidence for spontaneous resolution. Transplant Proc 23:1448–1451PubMed Noack KB, Wiesner RH, Batts K et al. (1991) Severe ductopenic rejection with features of vanishing bile duct syndrome:clinical,biochemical and histological evidence for spontaneous resolution. Transplant Proc 23:1448–1451PubMed
2.
go back to reference Wiesner RH, Ludwig J, Krom RAF et al. (1993) Hepatic allograft rejection:new developments in terminology,diagnosis,precention and treatment. Mayo Clin Proc 68:69–79CrossRefPubMed Wiesner RH, Ludwig J, Krom RAF et al. (1993) Hepatic allograft rejection:new developments in terminology,diagnosis,precention and treatment. Mayo Clin Proc 68:69–79CrossRefPubMed
3.
4.
go back to reference Munakata T, Griffiths RD, Martin PA et al. (1993) An in vivo 31PMRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity. NMR Biomed 6:168–172CrossRefPubMed Munakata T, Griffiths RD, Martin PA et al. (1993) An in vivo 31PMRS study of patients with liver cirrhosis: progress towards a non-invasive assessment of disease severity. NMR Biomed 6:168–172CrossRefPubMed
5.
go back to reference Menon DK, Sargentoni J, Taylor-Robinson SD et al. (1995) Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 21:417–427PubMed Menon DK, Sargentoni J, Taylor-Robinson SD et al. (1995) Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 21:417–427PubMed
6.
go back to reference Taylor-Robinson SD, Thomas EL, Sargentoni J et al. (1995) Cirrhosis of the human liver: An in vitro 31P nuclear magnetic resonance study. Biochim Biophys Acta 1272:113–118CrossRefPubMed Taylor-Robinson SD, Thomas EL, Sargentoni J et al. (1995) Cirrhosis of the human liver: An in vitro 31P nuclear magnetic resonance study. Biochim Biophys Acta 1272:113–118CrossRefPubMed
7.
go back to reference European FK506 multicenter liver study group. (1994) Randomised trial comparing tacrolimus(FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 344:423–428CrossRef European FK506 multicenter liver study group. (1994) Randomised trial comparing tacrolimus(FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 344:423–428CrossRef
8.
go back to reference Malloy CR, Cunningham CC, Radda CK (1986) The metabolic state of the rat liver in vivo measured by 31P-NMR spectroscopy. Biochim Biopys Acta 885:1CrossRef Malloy CR, Cunningham CC, Radda CK (1986) The metabolic state of the rat liver in vivo measured by 31P-NMR spectroscopy. Biochim Biopys Acta 885:1CrossRef
9.
go back to reference Uberbaenshi RD, Galloway GJ, Taylor LJ et al. (1986) Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy. Br J Radiol 59:695CrossRef Uberbaenshi RD, Galloway GJ, Taylor LJ et al. (1986) Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy. Br J Radiol 59:695CrossRef
10.
go back to reference Tang ZQ, Zhu SN, Cao SL et al. (1993) Modern Oncology. Shanghai Medical university publishing house, Shanghai, pp 47–50 Tang ZQ, Zhu SN, Cao SL et al. (1993) Modern Oncology. Shanghai Medical university publishing house, Shanghai, pp 47–50
11.
go back to reference Ruiz-Cabello J, Cohen JS (1992) Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 5:226–233CrossRefPubMed Ruiz-Cabello J, Cohen JS (1992) Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 5:226–233CrossRefPubMed
12.
go back to reference Taylor-Robinson SD,Sargentoni J,Bell JD et al. (1998) In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts. Gut 42:735–743CrossRefPubMedPubMedCentral Taylor-Robinson SD,Sargentoni J,Bell JD et al. (1998) In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts. Gut 42:735–743CrossRefPubMedPubMedCentral
13.
go back to reference Murphy EJ, Brindle KM, Rorison CJ et al. (1992) Changes in phosphatidylethanolamine metabolism in regenerating rat liver as measured by P-31 NMR. Biochem Biophys Acta 1135:27–34CrossRefPubMed Murphy EJ, Brindle KM, Rorison CJ et al. (1992) Changes in phosphatidylethanolamine metabolism in regenerating rat liver as measured by P-31 NMR. Biochem Biophys Acta 1135:27–34CrossRefPubMed
14.
go back to reference Taylor-Robinson SD,Sargentoni J, Bell JD et al. (1997) In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver 17:198–209CrossRefPubMed Taylor-Robinson SD,Sargentoni J, Bell JD et al. (1997) In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver 17:198–209CrossRefPubMed
15.
go back to reference Murphy EJ, Rajagopalan B, Brindle KM et al. (1989) Phospholipid bilayer contribution to 31P-NMR spectro in vivo. Magn Reson Med 12:282–289CrossRefPubMed Murphy EJ, Rajagopalan B, Brindle KM et al. (1989) Phospholipid bilayer contribution to 31P-NMR spectro in vivo. Magn Reson Med 12:282–289CrossRefPubMed
16.
go back to reference Mann DV, Lam WWM, Magnus HN et al. (2002) Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a phosphorus-31 magnetic resonance spectroscopy study. Gut 50:118–122CrossRefPubMedPubMedCentral Mann DV, Lam WWM, Magnus HN et al. (2002) Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a phosphorus-31 magnetic resonance spectroscopy study. Gut 50:118–122CrossRefPubMedPubMedCentral
17.
go back to reference Shinkwin MA, Lenkmask PE, Daly JM et al. (1991) Integrated magnetic resonance imaging and phosphorus spectroscopy of soft tissue tumors. Cancer 67:1849–1858CrossRefPubMed Shinkwin MA, Lenkmask PE, Daly JM et al. (1991) Integrated magnetic resonance imaging and phosphorus spectroscopy of soft tissue tumors. Cancer 67:1849–1858CrossRefPubMed
18.
go back to reference Oberhaensli RD, Bore PJ, Rampling RP et al. (1998) Biochemical investigation of human tumors in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet 5:8–11 Oberhaensli RD, Bore PJ, Rampling RP et al. (1998) Biochemical investigation of human tumors in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet 5:8–11
19.
go back to reference Ng TC, Majory AW, Vijayakumar S et al. (1989) Human neoplasm pH and response to radiation therapy: 31P MR spectroscopy studies in situ. Radiology170:875–878CrossRefPubMed Ng TC, Majory AW, Vijayakumar S et al. (1989) Human neoplasm pH and response to radiation therapy: 31P MR spectroscopy studies in situ. Radiology170:875–878CrossRefPubMed
20.
go back to reference Rubin R, Munoz SJ (1993) Clinicopathologic features of late hepatic dysfunction in orthotopic liver transplants. Hum Pathol 24:643–651CrossRefPubMed Rubin R, Munoz SJ (1993) Clinicopathologic features of late hepatic dysfunction in orthotopic liver transplants. Hum Pathol 24:643–651CrossRefPubMed
Metadata
Title
RETRACTED ARTICLE: Diagnosis of rejection after liver transplantation: use of phosphorus-31 magnetic resonance spectroscopy (31P-MRS)
Authors
Tao Jiang
Shiyuan Liu
XiangSheng Xiao
XiaoFeng Tao
GuangHua Liu
JinLin Wang
Publication date
01-10-2012
Publisher
Springer US
Published in
Abdominal Radiology / Issue 5/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-008-9451-1

Other articles of this Issue 5/2012

Abdominal Radiology 5/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.